Compare HKIT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HKIT | NTRB |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.6M | 71.7M |
| IPO Year | 2023 | N/A |
| Metric | HKIT | NTRB |
|---|---|---|
| Price | $1.99 | $4.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 607.0K | 23.1K |
| Earning Date | 04-08-2026 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,812,901.00 | ★ $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $1.15 | $3.72 |
| 52 Week High | $4.18 | $11.78 |
| Indicator | HKIT | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 54.44 | 35.47 |
| Support Level | $1.42 | $4.35 |
| Resistance Level | $2.59 | $4.77 |
| Average True Range (ATR) | 0.20 | 0.42 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 51.85 | 7.25 |
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.